On Wednesday, the Supreme Court’s ruling in Campbell-Ewald Company v. Gomez placed serious limits on a strategy some companies have employed to dispose of class cases quickly. The Court held that a company cannot moot a...more
In this Issue:
- New Developments
- U.S. Supreme Court Will Decide Whether Patent Agreements That Postpone the Sale of Generic Drugs Violate Antitrust Laws
- Direct Purchasers Have Standing to Bring Antitrust...more
12/1/2013
/ Antitrust Litigation ,
Barclays ,
Department of Justice (DOJ) ,
Direct Purchasers ,
Federal Trade Commission (FTC) ,
Fraudulent Procurement ,
Generic Drugs ,
Interest Rates ,
Libor ,
Patents ,
Pay-For-Delay ,
Reverse Payment Settlement Agreements ,
SCOTUS ,
Sherman Act ,
Walker Process Claims ,
Wireless Devices